351370-99-5 Usage
Uses
Used in Pharmaceutical Synthesis:
5-BOC-OCTAHYDRO-PYRROLO[3,4-C]PYRIDINE is used as an intermediate compound in the synthesis of pharmaceuticals. Its unique structure and reactivity make it a valuable component in the development of new drugs and medications.
Used in Agrochemical Production:
In the agrochemical industry, 5-BOC-OCTAHYDRO-PYRROLO[3,4-C]PYRIDINE is used as a key component in the production of various agrochemicals. Its role in the synthesis of these compounds contributes to the development of effective pesticides, herbicides, and other agricultural products.
Used in Chemical Research:
5-BOC-OCTAHYDRO-PYRROLO[3,4-C]PYRIDINE is employed as a research compound in various chemical studies. Its properties and reactivity are of interest to scientists and researchers who are exploring new chemical reactions, mechanisms, and potential applications in different fields.
Used in Industrial Manufacturing:
5-BOC-OCTAHYDRO-PYRROLO[3,4-C]PYRIDINE is utilized in industrial manufacturing processes, where its chemical properties are harnessed to produce a range of products. Its versatility and reactivity make it a valuable component in the production of various industrial chemicals and materials.
Check Digit Verification of cas no
The CAS Registry Mumber 351370-99-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,1,3,7 and 0 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 351370-99:
(8*3)+(7*5)+(6*1)+(5*3)+(4*7)+(3*0)+(2*9)+(1*9)=135
135 % 10 = 5
So 351370-99-5 is a valid CAS Registry Number.
InChI:InChI=1/C12H22N2O2/c1-12(2,3)16-11(15)14-5-4-9-6-13-7-10(9)8-14/h9-10,13H,4-8H2,1-3H3
351370-99-5Relevant articles and documents
ISOQUINOLINESULFONYL DERIVATIVE AS RHO KINASE INHIBITOR
-
Paragraph 0132; 0141; 0142, (2017/06/12)
The present invention discloses a class of isoquinolinesulfonyl derivatives as RHO kinase inhibitors, and pharmaceutical compositions thereof, and relates to pharmaceutically acceptable uses thereof. Specifically, the present invention relates to a compound as represented by formula (I), or a pharmaceutically acceptable salt thereof.
AMINOQUINAZOLINE DERIVATIVES AND THEIR SALTS AND METHODS OF USE
-
Paragraph 0527-0528, (2014/08/19)
The present invention relates to the field of medicine. Provided herein are aminoquinazoline derivatives, their salts and pharmaceutical formulations useful in modulating the protein tyrosine kinase activity, and in modulating inter- and/or intra-cellular signaling. Also provided herein are pharmaceutically acceptable compositions comprising the aminoquinazoline compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.
AMINOQUINAZOLINE DERIVATIVES AND THEIR SALTS AND METHODS OF USE
-
Paragraph 00336, (2013/06/05)
The present invention relates to the field of medicine. Provided herein are aminoquinazoline derivatives, their salts and pharmaceutical formulations useful in modulating the protein tyrosine kinase activity, and in modulating inter-and/or intra-cellular signaling. Also provided herein are pharmaceutically acceptable compositions comprising the aminoquinazoline compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.
